Retinoblastoma Biomarker Study
NCT00342797
·
clinicaltrials.gov ↗
COMPLETED
Status
2136
Enrollment
NIH
Sponsor class
Conditions
Retinoblastoma
Melanoma
Sarcoma
Sponsor
National Cancer Institute (NCI)